Liberty Health Sciences Inc OTCMKTS: LHSIF Appointed Sheri Cholodofsky as Chief Financial Officer

838

Liberty Health Sciences Inc OTCMKTS: LHSIF is the cannabis provider committed to providing a trusted, high quality cannabis experience based on our genuine care for all cannabis users and a focus on operational excellence from seed to sale. Liberty’s measured approach to expansion opportunities is focused on maximizing returns to shareholders, while keeping consumers’ well-being at the forefront of what we do.

Liberty Health Sciences Inc OTCMKTS: LHSIF On May 22, 2019 announced that Sheri Cholodofsky has been appointed Chief Financial Officer, subject to Florida Department of Health approval. Cholodofsky replaces Jeff Chan, Liberty’s Vice President, Finance who served as interim Chief Financial Officer following the previously announced resignation of Rene Gulliver as Chief Financial Officer effective April 14, 2019. Chan will resume his duties at Liberty as Vice President, Finance and will work closely with Cholodofsky during this transition period.

As previously announced, Liberty continues to work towards increasing its U.S.-based directors and senior executive team, to more closely align with its operations in the United States. The Company also continues to search for a U.S.-based executive to fill the Chief Executive Officer position.

“I am thrilled to welcome Sheri as the next CFO of Liberty,” said Victor Mancebo, Interim Chief Executive Officer of Liberty. “Her knowledge and contributions will be a valuable addition to our senior leadership team as we work together to drive decisions that are in the best interest of our patients and shareholders. Additionally, I want to thank Jeff for his dedication and support over the past several months as our interim CFO. His leadership enabled a seamless transition following the departure of the Company’s former CFO and he will continue to serve as a key member of our senior leadership team.”

Sheri Cholodofsky, Chief Financial Officer

As Chief Financial Officer, Cholodofsky will be responsible for leading the Company’s finance function and working with the Liberty executive leadership team on the strategic direction of the Company.

Cholodofsky is an accomplished certified public accountant based in Florida and has extensive experience in finance, accounting, human resources, operations management and driving capital market and M&A activities. She began her career in public accounting with global accounting firm BDO and then continued to hold the senior finance and accounting role for 14 years with Creative Staffing, an executive recruiting and human resources company.

In 2009 Cholodofsky joined Miami Air International where she worked for nine years in the highly regulated aviation industry. She headed up all aspects of the finance and accounting department including financial statement reporting, budgeting, analysis, cash flow management, cost reduction programs, and fraud prevention. She also secured a central role on the Executive Strategy Team, evaluating major capital projects, strategic partnerships, fleet management and M&A opportunities.

Cholodofsky received her Bachelor of Science degree in accounting from the University of Florida and a Master of Accounting degree from Florida International University.

“Sheri joins our Company at a very exciting time as we pursue an aggressive growth strategy supported by our state-of-the-art medical cannabis manufacturing facility located in Gainesville, Florida,” said Mancebo. “Sheri will work closely with Liberty’s executive leadership team and the board to help advance our Company’s vision and unique position in the cannabis industry.”

Liberty Health Sciences Inc OTCMKTS: LHSIF On May 6, 2019 announced that it will open its 14th Florida dispensary in Cape Coral’s South Cape business district on Friday, May 10th, subject to Florida Department of Health approval. This is the first medical facility to open in Cape Coral and Liberty’s second dispensary to open in Lee County.

LEAVE A REPLY